The temporal order of genetic and pathway alterations in tumorigenesis.
about
Bioinformatics for cancer immunology and immunotherapyCancer evolution: mathematical models and computational inferenceSynergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cellsLearning oncogenetic networks by reducing to mixed integer linear programming.Harnessing the complexity of gene expression data from cancer: from single gene to structural pathway methodsTemporal ordering of cancer microarray data through a reinforcement learning based approach.Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.Integrating mutation and gene expression cross-sectional data to infer cancer progression.Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas.Simultaneous identification of multiple driver pathways in cancerOncogenic Ras stimulates Eiger/TNF exocytosis to promote growth.Using passenger mutations to estimate the timing of driver mutations and identify mutator alterationsInferring the temporal order of cancer gene mutations in individual tumor samplesInferring tree causal models of cancer progression with probability raising.A computational model incorporating neural stem cell dynamics reproduces glioma incidence across the lifespan in the human populationIdentifying restrictions in the order of accumulation of mutations during tumor progression: effects of passengers, evolutionary models, and sampling.Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgraftsDynamics of preventive vs post-diagnostic cancer control using low-impact measures.Defining order and timing of mutations during cancer progression: the TO-DAG probabilistic graphical modelPhylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.The p53 protein does not facilitate adenovirus type 5 replication in normal human cells.Mathematical models for translational and clinical oncology.Variable selection for disease progression models: methods for oncogenetic trees and application to cancer and HIV.Genetic load makes cancer cells more sensitive to common drugs: evidence from Cancer Cell Line Encyclopedia.Progression inference for somatic mutations in cancer.Computational approaches for the identification of cancer genes and pathwaysLhx3 is required to maintain cancer cell development of high-grade oligodendroglioma.Large-scale inference of conjunctive Bayesian networks.Identification of neutral tumor evolution across cancer types.MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel diseaseThe effect of one additional driver mutation on tumor progression.Cancer Progression Models and Fitness Landscapes: a Many-to-Many Relationship.Oncogenicity of LHX4 in colorectal cancer through Wnt/β-catenin/TCF4 cascade.Mutational interactions define novel cancer subgroupsTiming somatic events in the evolution of cancer
P2860
Q26864876-D8F630CE-E142-41FE-8022-217B1643EB89Q27002537-E1866413-DD9B-4E89-875D-C3A5DFE3F952Q28485464-61260DC8-4A7C-4512-960C-85B51A87C509Q30540654-2C662A6D-7629-4235-84DE-18D68DA63122Q30580995-81F250EF-2EB0-460C-AC90-C286ED34C98DQ30613258-17A61948-1BE3-4A39-B8F4-24688AD9F440Q30912170-284FABC0-BF97-4172-B677-5E7AF9D8E394Q31039903-74822179-BCAA-49CE-A81C-7EB9FAC8A777Q33777905-BE0E9285-84C1-415E-8549-0254A594B547Q34743718-63EDB40C-C032-4B5F-8F2E-5043115EBB96Q34985765-C331289F-A448-4AC2-BE9C-C48DD95B3673Q35065185-CA755CE3-1BEE-4592-9FE9-62BC327683E0Q35106921-CFB13BDC-AC52-4D5F-A62C-AFAA6FADAE3EQ35316887-2E9D28FC-3E96-4D20-98A6-5A1B8428E463Q35436721-1A121F45-DC35-48B9-B565-1965646303DDQ35602998-59D85137-C095-4D17-8172-8F1F258F4243Q35798540-3269C581-0090-4FBE-9142-163864866CEAQ35914889-989ABC3F-8265-4FE1-93B4-2A893C69228CQ36149716-7D24868C-E698-4F93-9DB6-5952EAFA3E64Q36774411-E3DA7597-F6AE-47EB-92A0-2F3B65248954Q36827260-F57DB099-8544-4F6F-B043-58E8AC2C8E2CQ38160282-DB77597B-1D51-4342-B4AE-1191F536AF96Q38648550-8558F67A-8846-4541-BB32-F2C3DC679BDBQ38703264-DD8E5D4C-2C25-4D86-8EB4-F2961DB1CCAAQ38793244-E90EDF52-E6D1-4514-9CED-E981FC5C669AQ38793593-69482538-B799-4AD3-A3B9-7FE26A7D188BQ38940251-72BF58D9-AC9B-44E2-A92B-3DD0E8CFBF64Q39429304-FF870C47-380B-4A7C-9DED-1BBCE43C7170Q40093976-2CFD819F-2F81-4191-9917-0D3A4A81A7A8Q41839952-FFEBD734-5595-486C-88B1-CB35D9E08C5AQ41846748-5C4C7C5D-8C66-43BB-9929-2846BF06702DQ47313036-68CF1026-850A-4986-AF5B-1DAE31635257Q50648214-0F47F28D-299C-436A-B9B1-6A455EDA24BEQ57810947-16B26F12-CC1F-4E94-95DA-AFED3712F7BBQ58063735-055553A1-B5D5-4F25-A3A0-8E485E38DD43
P2860
The temporal order of genetic and pathway alterations in tumorigenesis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The temporal order of genetic and pathway alterations in tumorigenesis.
@ast
The temporal order of genetic and pathway alterations in tumorigenesis.
@en
The temporal order of genetic and pathway alterations in tumorigenesis.
@nl
type
label
The temporal order of genetic and pathway alterations in tumorigenesis.
@ast
The temporal order of genetic and pathway alterations in tumorigenesis.
@en
The temporal order of genetic and pathway alterations in tumorigenesis.
@nl
prefLabel
The temporal order of genetic and pathway alterations in tumorigenesis.
@ast
The temporal order of genetic and pathway alterations in tumorigenesis.
@en
The temporal order of genetic and pathway alterations in tumorigenesis.
@nl
P2860
P50
P1433
P1476
The temporal order of genetic and pathway alterations in tumorigenesis.
@en
P2093
Nicholas Eriksson
P2860
P304
P356
10.1371/JOURNAL.PONE.0027136
P407
P577
2011-11-01T00:00:00Z